More on ARCT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.74 |
|
|||
| Open | $14.29 | ||||
| 52 Wk High | $13.09 | ||||
| 52 Wk Low | $5.54 | ||||
| Day High | $14.33 | ||||
| Day Low | $13.12 | ||||
| P/E | N/A | ||||
| EPS | $-0.38 | ||||
| Volume | 428,324 | ||||
- Form 8-K Arcturus Therapeutics For: Aug 25
- Arcturus Therapeutics (ARCT) Tops Q2 EPS by 21c
- Form 10-Q Arcturus Therapeutics For: Jun 30
- Form 8-K Arcturus Therapeutics For: Aug 06
- Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
- Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
- Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
- Form 8-K Arcturus Therapeutics For: Jun 26
- Arcturus and Thermo Fisher partner on cystic fibrosis mRNA therapy
- Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
Entities mentioned with ARCT
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
